Singapore-based digital innovation center Lumenlab is testing a blockchain-enabled insurance solution for diabetes sufferers, according to a press release published August 20.
Lumenlab is a subsidiary of financial services provider MetLife (NYSE:MET) and has reportedly developed the new project within the Monetary Authority of Singapore’s (MAS) regulatory sandbox.